ASTION PHARMA A/S: Financial statements 2019
CVR: 34224781
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,831,910 and a net result of DKK -1,767,025 compared with DKK -409,449 the year before.
- Gross Profit
- DKK -1,831,910
- Profit/Loss
- DKK -1,767,025
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -1.8M | -1.8M | - | - |
| 2018 | - | -392K | -409K | 500K | - |
| 2017 | - | -48K | -1.5M | 7.7M | 0 |
| 2016 | - | -187K | 117K | 15.7M | 0 |
| 2015 | - | -783K | -5.8M | 15.6M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ASTION PHARMA A/S has published its annual report for 2018. Gross profit came to DKK -392,051, and the net result was DKK -409,449.
As of May 21, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of ASTION PHARMA A/S.
As of May 21, 2019, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ASTION PHARMA A/S.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.